Seroatlas · Human Serome Atlas

SNCG

Gamma-synuclein

Also known as: BCSG1, persyn, SR, SYUG_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O76070
Gene
SNCG
Ensembl
ENSG00000173267
Chromosome
10
Canonical length
127 aa
Protein class
Predicted intracellular proteins, Transporters
Subcellular location
Golgi apparatus,Centrosome,Cytosol

OverviewNCBI Gene

This gene encodes a member of the synuclein family of proteins which are believed to be involved in the pathogenesis of neurodegenerative diseases. Mutations in this gene have also been associated with breast tumor development. [provided by RefSeq, Jan 2010]

Canonical amino-acid sequenceUniProt

127 residues, UniProt reviewed canonical sequence.

>O76070|SNCG
     1  MDVFKKGFSI AKEGVVGAVE KTKQGVTEAA EKTKEGVMYV GAKTKENVVQ SVTSVAEKTK
    61  EQANAVSEAV VSSVNTVATK TVEEAENIAV TSGVVRKEDL RPSAPQQEGE ASKEKEEVAE
   121  EAQSGGD

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SNCG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.54
Highest tissue expression
638 nTPM

Expression across tissuesHPA

Tissue

  • hypothalamus: 638 nTPM
  • amygdala: 605 nTPM
  • midbrain: 434 nTPM
  • cerebral cortex: 355 nTPM
  • blood vessel: 340 nTPM
  • adrenal gland: 300 nTPM

Single-cell type

  • urothelial cells: 2,089 nCPM
  • esophageal apical cells: 709 nCPM
  • prostatic club cells: 656 nCPM
  • vascular smooth muscle cells: 577 nCPM
  • prostatic hillock cells: 570 nCPM
  • lymphatic endothelial cells: 440 nCPM

Immune cell

  • classical monocyte: 0.7 nTPM
  • naive CD4 T-cell: 0.3 nTPM
  • non-classical monocyte: 0.2 nTPM
  • myeloid DC: 0.1 nTPM
  • total PBMC: 0.1 nTPM
  • basophil: 0 nTPM

Brain region

  • medulla oblongata: 794 nTPM
  • hypothalamus: 750 nTPM
  • pons: 730 nTPM
  • cerebral cortex: 575 nTPM
  • thalamus: 565 nTPM
  • midbrain: 512 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about SNCG.

Disease | ImmuneIEDB

Conditions an epitope on SNCG was assayed in.

ReferencesPubMed · IEDB

Publications for SNCG from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: T cellIEDB

1 publication

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.63
gnomAD pLI
0
gnomAD missense Z
0.23
DepMap mean gene effect
-0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SNCG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SNCG as an antibody target. Whether an autoantibody or antibody against SNCG could matter depends on whether native SNCG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SNCG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label SNCG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SNCG. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...